510(k) K220480
K220480 is an FDA 510(k) premarket notification submitted by Meridian Bioscience, Inc. for the device "Revogene". The FDA issued a decision of Substantially Equivalent on Jul 11, 2022. The device falls under product code OOI (Real Time Nucleic Acid Amplification System), a Class II device regulated under 21 CFR 862.2570. Meridian Bioscience, Inc. has 37 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jul 11, 2022
- Date Received
- Feb 18, 2022
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Real Time Nucleic Acid Amplification System
- Device Class
- Class II
- Regulation Number
- 862.2570
- Review Panel
- CH
- Submission Type
- 510(k) Exempt
The system is a clinical multiplex instrument intended to measure and sort multiple signals generated my multiple probes, intercalating dyes, or other ligands in an assay from a clinical sample. Signals may be generated by fluorescence or other phenomena and may be measured using filters on a photodiode or other detector. It may integrate sample and/or reagent handling, amplification, dedicated instrument control, data acquisition software, raw data storage mechanisms and other essential hardware components along with the signal reader unit. The system is used with specific assays to comprise an assay test system.
Need the full FDA record for Meridian Bioscience, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.